ASCENT: Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Expert oncologists Aditya Bardia, MD, MPH, and Alison Conlin, MD, review clinical data behind the use of sacituzumab govitecan in metastatic TNBC from the phase 3 ASCENT study.